Health company Essity stated on Wednesday that it has scaled up the production of its Tork-branded hand sanitizers capacity to meet the increased demand in Europe following the challenges, impact and focus of the COVID-19 pandemic on hand hygiene.
In the Q4 2020, the company will increase its supply capacity of hand sanitizer in Europe to enable the continued high growth of the existing range. Its Professional Hygiene business, under the leading global brand Tork, has seen a steep increase in demand for hand sanitizers in response to new hygiene regulations or customers' desire to provide an additional layer of safety where water and soap are not available.
Based on the research conducted on the company's behalf in July 2020, the hand hygiene is now an integral part of everyday routines and that 74% of people now consider hand hygiene to be more a part of their overall health routine than before the COVID-19 pandemic. About 69% of respondents find hand sanitizers a good complement to washing hands.
With an increase in the sanitizer capacity, the businesses and their employees and customers can offer consistent and reliable access to hand-hygiene products when handwashing is not readily available, concluded the company.
Tyra Biosciences doses first patient in TYRA-300 Phase 2 study for bladder cancer
argenx advances ARGX-119 to registrational study for congenital myasthenic syndromes
hVIVO supports Cidara Therapeutics' positive Phase 2b influenza study results
Sanofi's riliprubart receives orphan drug designation in Japan for CIDP
HUTCHMED gains China approval for ORPATHYS and TAGRISSO combination in lung cancer
Hikma Pharmaceuticals USA announces USD1bn of new US investment
UCB reports positive Phase 3 results for fenfluramine in CDKL5 deficiency disorder